STOCKSERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINEUpdated 2026-06-07
Here’s whether Teladoc Health, Inc. (TDOC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.88% over 10 days); RSI 61 — healthy momentum range; 3-month momentum positive (+33.0%). Currently 27.8% off its 52-week high. Score: +6/7.
TDOC is in a confirmed uptrend, trading above both its 50-day ($6.22) and 200-day ($6.80) moving averages. An RSI of 61.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +1.7% compares to +24.4% for SPY (trailed the market by 22.6%). The current 27.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $10,173 today
vs. S&P 500 (SPY) — same period trailed market by 22.6%